Ian McKellen and Vas Narasimhan are prominent figures in entirely different fields, and there is no verified public evidence of a personal, professional, family, or business relationship between them. McKellen is a celebrated British stage and screen actor, while Narasimhan is an American physician-scientist and the chief executive officer of Swiss pharmaceutical company Novartis.
A review of official biographies, organizational records, company disclosures, reputable news coverage, and searches for the two names together found no credible source documenting a collaboration or direct connection as of September 2026. The pairing should therefore not be treated as evidence that the two men have worked together or share a known relationship.
Ian McKellen and Vas Narasimhan at a Glance
| Detail | Ian McKellen | Vas Narasimhan |
|---|---|---|
| Full name | Ian Murray McKellen | Vasant “Vas” Narasimhan |
| Main field | Acting and theatre | Medicine and pharmaceutical leadership |
| Born | 25 May 1939 | 1976 |
| Nationality/background | English actor | American physician-scientist |
| Best known for | Shakespeare, Gandalf, Magneto | CEO of Novartis |
| Major public role | Actor and LGBTQ+ equality campaigner | Pharmaceutical executive and healthcare leader |
| Current position/status | Active actor, returning to the London stage in 2026 | Novartis CEO since 2018 |
| Verified direct connection | No reliable public evidence located | No reliable public evidence located |
McKellen’s official biography confirms his birth date, long theatre career, major screen roles and activism. Novartis identifies Narasimhan as an American born in 1976 who has served as the company’s CEO since February 2018.
Is There a Verified Ian McKellen and Vas Narasimhan Relationship?
No reliable public source located for this article establishes a relationship between Ian McKellen and Vas Narasimhan.
There is no verified evidence that they have:
- worked on the same professional project
- served together on a corporate board
- been business partners
- belonged to the same immediate family
- jointly led a charity or organization
- announced a public collaboration
- held positions at the same employer
That distinction matters because search engines can place two well-known names together without the pairing representing a real-world relationship. An exact-name search alone is not evidence that two public figures know or work with each other.
Their official career records also point to very different professional networks. McKellen’s documented career centers on theatre, film and equality activism, while Narasimhan’s career has been built in medicine, drug development, public health and corporate leadership.
Who Is Ian McKellen?
Sir Ian McKellen is an English actor whose career has extended from classical British theatre to some of the world’s most commercially successful film franchises.
Born in Burnley, England, on 25 May 1939, McKellen began acting while young and later studied at the University of Cambridge. His professional stage career dates to 1961, according to his official biography.
His theatre career
Theatre is central to McKellen’s career. He has performed with institutions including the Royal Shakespeare Company and Britain’s National Theatre and has played major Shakespearean characters such as Richard II, Macbeth, Iago, Richard III and King Lear.
His Broadway performance as Salieri in Amadeus was another major part of his stage career, while productions including Waiting for Godot and No Man’s Land paired him with longtime friend and fellow actor Patrick Stewart.
McKellen’s impact extends beyond individual roles. In 2019, The Stage placed him at the top of its Stage 100 list, making him the first actor to hold the number-one position, according to his official biography.
Gandalf, Magneto and his film career
For global cinema audiences, McKellen is especially associated with two characters.
He played Magneto, also known as Erik Lehnsherr, in the X-Men film series and Gandalf in Peter Jackson’s The Lord of the Rings and The Hobbit films.
McKellen has also appeared in movies including Gods and Monsters, The Da Vinci Code, Mr Holmes, Beauty and the Beast, All Is True and The Good Liar. He received Academy Award nominations for Gods and Monsters and The Lord of the Rings: The Fellowship of the Ring.
Ian McKellen remains professionally active in 2026
McKellen has not retired.
The Yard Theatre in London currently lists him as the star of Lear, a new reimagining of Shakespeare’s King Lear by Simon Stephens and Jay Miller. The sold-out production is scheduled to run from 17 November 2026 through 2 January 2027.
The production is particularly notable because it marks his return to a major live theatre role following his 2024 stage accident. Contemporary theatre reporting says he fell during a performance of Player Kings, after which he withdrew from the production while recovering.
His official website also lists him among the cast of the forthcoming The Lord of the Rings: The Hunt for Gollum, currently scheduled for release on 17 December 2027.
Ian McKellen’s Work Outside Acting
McKellen has also had a major public role in LGBTQ+ equality campaigning.
He was one of the founders of Stonewall UK, created in 1989 following opposition to Section 28. Stonewall’s own historical record states that its early aims were developed at a meeting at McKellen’s home and lists him among the organization’s founding figures.
Stonewall presented McKellen with a Lifetime Achievement Award in October 2024 for his decades of activism.
His public honours include a knighthood for services to the performing arts and appointment as a Companion of Honour for services to drama and equality.
Who Is Vas Narasimhan?
Vasant “Vas” Narasimhan is a physician-scientist and pharmaceutical executive who has served as chief executive officer of Novartis since 2018.
He was born in the United States in 1976 and grew up in Pittsburgh, Pennsylvania. His career has focused on medicine, drug development, public health and pharmaceutical management rather than entertainment or the performing arts.
Education and medical background
Narasimhan has an unusually strong medical and public-policy background for the chief executive of a major multinational corporation.
According to Novartis, he earned:
- a bachelor’s degree in biological sciences from the University of Chicago
- a medical degree from Harvard Medical School
- a master’s degree in public policy from Harvard University’s John F. Kennedy School of Government
During and after his medical studies, he also worked on public-health issues involving HIV/AIDS, malaria and tuberculosis in India, Africa and South America.
Also Read: Larry Page and Vas Narasimhan
Narasimhan’s Career at Novartis
Narasimhan joined Novartis in 2005 and moved through a series of senior positions involving vaccines, biopharmaceuticals and drug development.
His previous Novartis roles included Global Head of Development for Novartis Pharmaceuticals and Global Head of Drug Development and Chief Medical Officer. The company announced in September 2017 that he would succeed Joseph Jimenez as CEO, with the appointment taking effect on 1 February 2018.
Under Narasimhan, Novartis has increasingly focused on innovative medicines rather than operating as a broader healthcare conglomerate.
The company’s current strategy concentrates on four major therapeutic areas:
- cardiovascular, renal and metabolic disease
- immunology
- neuroscience
- oncology
Its prioritized technology platforms include radioligand therapy, gene and cell therapy and RNA-based approaches alongside more established drug technologies.
How Large Is Novartis Under Vas Narasimhan?
Novartis says it reached more than 300 million patients in 2025, employed roughly 77,000 people and sold products in more than 100 countries. These are company-reported figures rather than independently calculated patient counts.
Its 2025 financial results reported:
| Metric | 2025 result |
|---|---|
| Net sales | $54.532 billion |
| Operating income | $17.644 billion |
| Net income | $13.967 billion |
| Free cash flow | $17.596 billion |
Novartis reported an 8% increase in net sales at constant currencies for the year.
These figures describe the company Narasimhan manages. They should not be confused with Narasimhan’s personal wealth or income.
Vas Narasimhan’s Role Beyond Novartis
Narasimhan’s responsibilities expanded further in 2026.
In April 2026, artificial-intelligence company Anthropic announced that its Long-Term Benefit Trust had appointed Narasimhan to Anthropic’s board of directors. Anthropic said his experience developing medicines in a highly regulated industry would contribute to its governance as artificial intelligence becomes increasingly important in healthcare and science.
Anthropic’s current governance page continues to list Narasimhan among its directors.
Novartis also states that Narasimhan is involved with the Pharmaceutical Research and Manufacturers of America and has been elected to the U.S. National Academy of Medicine.
How Their Careers Differ
The biggest reason to be cautious about claims connecting the two men is the lack of meaningful professional overlap in the public record.
Ian McKellen’s professional world
McKellen’s documented work involves:
- theatre
- cinema
- television
- Shakespeare
- arts institutions
- LGBTQ+ equality advocacy
Vas Narasimhan’s professional world
Narasimhan’s documented work involves:
- medicine
- pharmaceutical research
- drug development
- biotechnology
- public health
- corporate management
- artificial-intelligence governance
Their influence is therefore significant but operates in fundamentally different sectors.
McKellen has shaped theatre and popular culture through performance and public advocacy. Narasimhan’s influence is tied to decisions about pharmaceutical research, medicine development and the strategic direction of one of the world’s largest drug companies.
Do Ian McKellen and Vas Narasimhan Share Any Organization?
No shared organization between them was verified in the reliable sources reviewed.
McKellen’s best-known organizational connection outside acting is Stonewall, which he helped establish. Narasimhan’s major institutional connections include Novartis, Anthropic and healthcare or academic organizations.
It would therefore be inaccurate to describe them as colleagues, partners or collaborators without new documentary evidence.
Could There Still Be an Undocumented Personal Connection?
It is theoretically possible for two public figures to have met privately or at an event without that meeting appearing in reputable public records. That possibility, however, is not enough to state that a relationship exists.
For factual reporting, the appropriate position is straightforward: no documented Ian McKellen and Vas Narasimhan connection was found in credible public sources available as of September 2026.
If a future interview, event record, photograph, corporate announcement or other reliable document demonstrates an interaction, the factual picture could change.
Frequently Asked Questions
Are Ian McKellen and Vas Narasimhan related?
There is no credible public evidence that Ian McKellen and Vas Narasimhan are related. Their official biographies describe different family backgrounds and professional histories.
Have Ian McKellen and Vas Narasimhan worked together?
No verified joint project, company, film, charity initiative or other professional collaboration was found in reliable public sources reviewed for this article.
What is Ian McKellen famous for?
Ian McKellen is best known for his extensive Shakespearean theatre career and his film roles as Gandalf in The Lord of the Rings and The Hobbit and Magneto in the X-Men franchise. He is also a prominent LGBTQ+ equality campaigner.
What does Vas Narasimhan do?
Vas Narasimhan is a physician-scientist and the CEO of Novartis, a position he has held since February 2018. He oversees the pharmaceutical company’s global medicines business and research-focused strategy.
Is Ian McKellen still acting in 2026?
Yes. The Yard Theatre has scheduled McKellen to perform in Lear from 17 November 2026 to 2 January 2027, and his official website also lists him for The Lord of the Rings: The Hunt for Gollum.
Is Vas Narasimhan still CEO of Novartis in 2026?
Yes. Novartis’s current executive committee and company biography continue to identify Vasant Narasimhan as chief executive officer.
Also Read: Cliff Asness and Vas Narasimhan
